SCHEMBL30337904

SCHEMBL30337904

Nc1c(C(=O)O)cccc1N1CC2(CN(c3cccc(C(=O)O)c3)C2)C1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 6/20 0.49
▸ KMT2A Q03164 5/20 0.49
▸ MEN1 O00255 4/20 0.49
▸ GAA P10253 3/20 0.49
▸ KDM4E B2RXH2 3/20 0.49
▸ HPGD P15428 3/20 0.49
▸ HSD17B10 Q99714 3/20 0.49
▸ KMO O15229 1/20 0.46
▸ CYP1A2 P05177 3/20 0.42
▸ CYP3A4 P08684 3/20 0.42
▸ CYP2D6 P10635 2/20 0.42
▸ CYP2C9 P11712 1/20 0.42
▸ CYP2C19 P33261 1/20 0.42
▸ L3MBTL1 Q9Y468 3/20 0.41
▸ MAPT P10636 2/20 0.41
▸ USP2 O75604 3/20 0.40
▸ POLB P06746 2/20 0.40
▸ MYC P01106 1/20 0.40
▸ HSPA1A P0DMV8 1/20 0.40
▸ ALOX15 P16050 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26154649 1.00 ALDH1A1 (0.49) ALDH1A1KMT2AMEN1GAAKDM4E
SCHEMBL25192439 0.90 ALDH1A1 (0.42) ALDH1A1KMT2AMEN1GAAKDM4E
SCHEMBL25197237 0.88 ALDH1A1 (0.46) ALDH1A1KMT2AMEN1HPGDHSD17B10
SCHEMBL26154653 0.86 ALDH1A1 (0.60) ALDH1A1KMT2AMEN1GAAKDM4E
SCHEMBL26154631 0.83 CASP6 (0.41) ALDH1A1GAAKDM4EHPGDHSD17B10
SCHEMBL26154664 0.82 ALDH1A1 (0.46) ALDH1A1KMT2AMEN1GAAKDM4E
SCHEMBL26154693 0.82 ALDH1A1 (0.45) ALDH1A1KMT2AMEN1GAAKDM4E
SCHEMBL30337518 0.82 ALDH1A1 (0.45) ALDH1A1KMT2AMEN1GAAKDM4E
SCHEMBL30337616 0.81 NPC1 (0.46) ALDH1A1GAAKDM4EHPGDHSD17B10
SCHEMBL26154637 0.81 NPC1 (0.46) ALDH1A1GAAKDM4EHPGDHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113754541-B Small molecule inhibitor of targeted EB virus nuclear antigen protein, preparation method and application thereof 深圳湾实验室 2025-01-03 — — CN disclosed
US-20230157996-A1 SMALL-MOLECULE INHIBITOR TARGETING EB VIRUS NUCLEAR ANTIGEN PROTEIN, PREPARATION METHOD AND USE THEREOF Shenzhen Bay Laboratory (CN) 2023-05-25 — — US disclosed
EP-4151621-A1 SMALL-MOLECULE INHIBITOR TARGETING EB VIRUS NUCLEAR ANTIGEN PROTEIN, PREPARATION METHOD THEREFOR AND USE THEREOF Shenzhen Bay Laboratory (CN) 2023-03-22 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230157996-A1 SMALL-MOLECULE INHIBITOR TARGETING EB VIRUS NUCLEAR ANTIGEN PROTEIN, PREPARATION METHOD AND USE THEREOF SSB, EBNA1BP2, PML ALDH1A1 4846/4885KMT2A 854/4885MEN1 763/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback